Photo of Peter Nilsson

Peter Nilsson

Professor

I am the head of a research group focusing on designing and synthesizing molecules that can be used within a variety of research areas and I teach in several courses related to applied organic chemistry.

Presentation

Multidisciplinary Applied Chemistry – Design and Synthesis of tools for Molecular Biology, Diagnostics and Therapeutics, as well as Bioelectronics and Biotechnology

My academic journey and research

I was born and raised in Linköping, but from 1996 to 2000, I went to Kalmar to study Chemistry at Linnaeus University and I performed my Master project in Chemistry at the University of Queensland, Brisbane, Australia. In 2001, I return to Linköping and started my Ph. D. studies at the Department of Physics, Chemistry and Biology (IFM), Linköping University (LiU) My mission as a Ph. D. student was to explore if conjugated polymers, a class of molecules frequently used in devices, such as solar cells and light emitting diodes, for organic electronics, could be applied as biosensors. I received my Ph.D. in Biomolecular and Organic Electronics in 2005. After receiving a multidisciplinary post-doctoral scholarship from the Knut and Alice Wallenberg Foundation (KAW), my academic carrier continued as a post-doc fellow in the research group of Prof. Adriano Aguzzi, at the Institute of Neuropathology, University of Zurich, Zurich, Switzerland and the aim of my project was to explore how luminescent conjugated oligo- and polythiophenes (LCOs) could be utilized as fluorescent ligands for revealing the pathological processes of the infectious prion diseases, such as Mad Cow disease and Creutzfeldt-Jacob disease, as well as other neurodegenerative diseases, such as Alzheimer’s disease (AD).

In 2008, I yet again returned to LiU, to start my own independent research group in organic chemistry at IFM and I was recruited within a novel program, LiU fo-ass, that aimed at fostering the next generation of research leaders at LiU. In addition, I also received the INGVAR CARLSSON award “ICA2” from the Swedish Foundation for Strategic Research (SSF), a research grant that aims to attract qualified postdoctoral researchers from abroad to start an independent, creative research career at a Swedish university. Due to my multidisciplinary academic track record, I have achieved valuable knowledge within a lot of different research areas including organic chemistry, biochemistry, applied physics, molecular biology and pathology, so it was obvious to continue to perform cross-disciplinary science. Hence, our research activities lie at the intersection of chemistry, physics, biochemistry materials science, and medicine, as our focus is to design and synthesize molecules that can be implemented within molecular biology, medicine, bioelectronics and biotechnology. Our research group therefore consists of researchers with a variety of scientific expertise’s and we also have several national and international academic collaborators within different areas of research.

I have been a professor of organic chemistry since 2015 and over the years, I have received numerous prestigious grants, including ERC-starting grant (European Research Council), Future Scientific Leaders 4 (SSF) and a VR consolidator grant (The Swedish Research Council) and over the years, our research have also been supported by research grants from the Swedish Research

Council, the Swedish Brain Foundation, the Swedish Alzheimer Foundation, the Swedish Parkinson foundation, the Torsten Söderberg Foundation, the Erling Persson Foundation, Konung Gustaf V:s och Drottning Victorias Foundation, STINT - The Swedish Foundation for International Cooperation in Research and Higher Education, the Promobilia foundation, the JM Dahls foundation, as well as the National Institute of Healths (NIH) and JPND research, an EU joint programme for neurodegenerative disease research. From a scientific perspective, our research tools have especially been transformative for studying disease-associated protein aggregates and at the moment we are highly focused on developing these tools further to generate the next generation of theranostics, combined therapeutics and diagnostic, that can aid in combating neurodegenerative diseases, such as AD.

Teaching

I am also involved in teaching activities related to different topics in chemistry. At the moment, I am responsible, as well as examiner, for Pharmaceutical Development (NKED20), Applied Chemistry (NKED24) and Molecular Synthesis (NKED26). My core philosophy in chemistry education is that “as a chemist you can do a lot of fun”, and as long as you understand the connection between synthesis, function and applications of molecules, you can work and apply your knowledge within pharmaceutical, forensic, environmental or material chemistry, as well as be involved in multidisciplinary research.

Innovations

Several of our academic findings are now being commercialized within the following spin-off companies: Ebba Biotech AB and Celluminova AB.

News

Peter Nilsson.

Peter Nilsson’s molecules shine a light on Alzheimer’s research

“Even though I’m a professor now, I still spend a lot of time in the lab, as I know that when I’m working hands on, that’s when I get the new ideas,” says Peter Nilsson. He develops tracer molecules that are used in research into Alzheimer’s disease.

Microscopy image of protein aggregates stained green and red with the tracer molecules.

Tracer molecules can distinguish between very similar brain diseases

Two diseases that affect the brain, Parkinson’s disease and multiple system atrophy, show the same characteristics. Scientists have now shown that tracer molecules developed at LiU can distinguish between these diseases.

Microscope image showing wellow and blue staining of irregular shapes.

New method gives hope in understanding Alzheimer’s disease

Scientists are now able to label proteins in the brains of mice who have a disease similar to Alzheimer’s disease. The new method allows the researchers to observe how harmful protein aggregates develop over a longer time period.

Publications

2025

Seyedehmahsa Mousavi, Therése Klingstedt, David Carrasco-Busturia, Ruben Vidal, Bernardino Ghetti, Mathieu Linares, Patrick Norman, Peter Nilsson (2025) Specific chemical determinants are central for achieving ligands for selective detection of amyloid-ß deposits in Alzheimer's disease Australian journal of chemistry (Print), Vol. 78, Article CH25095 (Article in journal) Continue to DOI
Domenic Burger, Marianna Kashyrina, Lukas Van Den Heuvel, Hortense De La Seigliere, Amanda J. Lewis, Francesco De Nuccio, Inayathulla Mohammed, Jeremy Verchere, Cecile Feuillie, Melanie Berbon, Marie-Laure Arotcarena, Aude Retailleau, Erwan Bezard, Marie-Helene Canron, Wassilios G. Meissner, Antoine Loquet, Luc Bousset, Christel Poujol, Peter Nilsson, Florent Laferriere, Thierry Baron, Dario Domenico Lofrumento, Francesca De Giorgi, Henning Stahlberg, Francois Ichas (2025) Synthetic a-synuclein fibrils replicate in mice causing MSA-like pathology Nature, Vol. 648, p. 409-417 (Article in journal) Continue to DOI
Greta Elovsson, Therése Klingstedt, Peter Nilsson, Ann-Christin Brorsson (2025) Diversity of Aß aggregates produced in a gut-based Drosophila model of Alzheimer's disease PLOS ONE, Vol. 20, Article e0314832 (Article in journal) Continue to DOI
Alina E. M. Schmidt, Sophie Steinhagen, Peter Nilsson, Ulrica Edlund, Agneta Richter-Dahlfors (2025) Spatial in situ mapping of cellulose and other biopolymers reveals the 3D tissue architecture in the green algae Ulva fenestrata International Journal of Biological Macromolecules, Vol. 320, Article 145632 (Article in journal) Continue to DOI
Gunilla T. Westermark, Ebba Nystrom, Sofie Nyström, Peter Nilsson, Per Hammarström, Per Westermark (2025) The question of strains in AA amyloidosis Scientific Reports, Vol. 15, Article 3684 (Article in journal) Continue to DOI

Organisation